Press Release Bluestar Genomics Presents Positive Results of its Pancreatic Cancer Test Performance Evaluation at 2022 ASCO GI Cancers Symposium ClearNote Health January 20, 2022
Press Release Bluestar Genomics Appoints David Mullarkey Chief Executive Officer ClearNote Health January 10, 2022
Press Release Bluestar Genomics Announces Plans to Present at the 40th Annual J.P. Morgan Healthcare Conference January 12 at 4:30 p.m. Eastern Time ClearNote Health January 6, 2022
